635 related articles for article (PubMed ID: 29514053)
1. The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.
Shafit-Zagardo B; Gruber RC; DuBois JC
Pharmacol Ther; 2018 Aug; 188():97-117. PubMed ID: 29514053
[TBL] [Abstract][Full Text] [Related]
2. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV
J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926
[TBL] [Abstract][Full Text] [Related]
3. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
Elife; 2014 Sep; 3():. PubMed ID: 25265470
[TBL] [Abstract][Full Text] [Related]
4. TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis.
van der Meer JH; van der Poll T; van 't Veer C
Blood; 2014 Apr; 123(16):2460-9. PubMed ID: 24596417
[TBL] [Abstract][Full Text] [Related]
5. The Gas6/TAM System and Multiple Sclerosis.
Bellan M; Pirisi M; Sainaghi PP
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801848
[TBL] [Abstract][Full Text] [Related]
6. TAM receptor signaling in development.
Burstyn-Cohen T
Int J Dev Biol; 2017; 61(3-4-5):215-224. PubMed ID: 28621419
[TBL] [Abstract][Full Text] [Related]
7. Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques.
Hurtado B; Muñoz X; Recarte-Pelz P; García N; Luque A; Krupinski J; Sala N; García de Frutos P
Thromb Haemost; 2011 May; 105(5):873-82. PubMed ID: 21384080
[TBL] [Abstract][Full Text] [Related]
8. TAM receptors in phagocytosis: Beyond the mere internalization of particles.
Burstyn-Cohen T; Fresia R
Immunol Rev; 2023 Oct; 319(1):7-26. PubMed ID: 37596991
[TBL] [Abstract][Full Text] [Related]
9. Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.
Ray AK; DuBois JC; Gruber RC; Guzik HM; Gulinello ME; Perumal G; Raine C; Kozakiewicz L; Williamson J; Shafit-Zagardo B
Glia; 2017 Dec; 65(12):2051-2069. PubMed ID: 28925029
[TBL] [Abstract][Full Text] [Related]
10. Post-translational modifications of the ligands: Requirement for TAM receptor activation.
Geng K
Int Rev Cell Mol Biol; 2020; 357():35-55. PubMed ID: 33234244
[TBL] [Abstract][Full Text] [Related]
11. TAM Receptor Pathways at the Crossroads of Neuroinflammation and Neurodegeneration.
Tondo G; Perani D; Comi C
Dis Markers; 2019; 2019():2387614. PubMed ID: 31636733
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells.
Al Kafri N; Hafizi S
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664510
[TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.
Kimani SG; Kumar S; Bansal N; Singh K; Kholodovych V; Comollo T; Peng Y; Kotenko SV; Sarafianos SG; Bertino JR; Welsh WJ; Birge RB
Sci Rep; 2017 Mar; 7():43908. PubMed ID: 28272423
[TBL] [Abstract][Full Text] [Related]
14. Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis.
Waterborg CEJ; Koenders MI; van Lent PLEM; van der Kraan PM; van de Loo FAJ
PLoS One; 2018; 13(10):e0205902. PubMed ID: 30335822
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions.
Weinger JG; Omari KM; Marsden K; Raine CS; Shafit-Zagardo B
Am J Pathol; 2009 Jul; 175(1):283-93. PubMed ID: 19541935
[TBL] [Abstract][Full Text] [Related]
16. Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.
Zhou J; Yang A; Wang Y; Chen F; Zhao Z; Davra V; Suzuki-Inoue K; Ozaki Y; Birge RB; Lu Q; Wu Y
Cell Commun Signal; 2018 Dec; 16(1):98. PubMed ID: 30541554
[TBL] [Abstract][Full Text] [Related]
17. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.
Seitz HM; Camenisch TD; Lemke G; Earp HS; Matsushima GK
J Immunol; 2007 May; 178(9):5635-42. PubMed ID: 17442946
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.
Kasikara C; Kumar S; Kimani S; Tsou WI; Geng K; Davra V; Sriram G; Devoe C; Nguyen KN; Antes A; Krantz A; Rymarczyk G; Wilczynski A; Empig C; Freimark B; Gray M; Schlunegger K; Hutchins J; Kotenko SV; Birge RB
Mol Cancer Res; 2017 Jun; 15(6):753-764. PubMed ID: 28184013
[TBL] [Abstract][Full Text] [Related]
19. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
[TBL] [Abstract][Full Text] [Related]
20. Duodenal mucosa of untreated celiac disease patients has altered expression of the GAS6 and PROS1 and the negative regulator tyrosine kinase TAM receptors subfamily.
Perez F; Iribarren ML; Olexen CM; Ruera CN; Errasti AE; Guzman L; Garbi L; Carrera Silva EA; Chirdo FG
Clin Immunol; 2024 Jun; 263():110202. PubMed ID: 38575045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]